Provider News Posts
Clinicians are encouraged to collaborate with patients receiving opioids at a dose above 90 MME and, if appropriate, taper/discontinue opioids to improve the safety of their drug regimen.
EVV training is required for providers per DHCS APL 22-014.
Statin can be used in patients with diabetes for primary and secondary prevention of ASCVD events.
On June 23, 2023 the Transition Policy for 46 drug classes will be retired.
A welcome note of gratitude
The American Geriatrics Society’s Beers Criteria lists benzodiazepines as potentially inappropriate medication in older adults.
Grants of $35,000-$100,000 are available now for Data Sharing Agreement (DSA) Signatories to build capacity for data exchange or to connect to a qualifying health information organization.
Part of the Implementation with Intention series
The deadline to apply for the Alliance’s one-time Care-Based Quality Improvement Program (CB QIP) is quickly approaching! Apply by Friday, May 19, 2023.
On May 19, 2023, Phase III, Lift 3 of the Medi-Cal Rx Claim Edits and Prior Authorization Reinstatement Plan will be implemented. This part of the plan lifts the Transition Policy for 22 additional drug classes.
Please review the updated Provider Manual, effective July 1, 2023, posted on the Alliance provider website.
On April 21, 2023, Phase III, Lift 2 of the Medi-Cal Rx Claim Edits and Prior Authorization Reinstatement Plan will be implemented.
An updated Alliance Provider Manual is now available, effective April 1, 2023. The new manual can be viewed on our provider website.
Contact Provider Services
General | 831-430-5504 |
Claims Billing questions, claims status, general claims information |
831-430-5503 |
Authorizations General authorization information or questions |
831-430-5506 |
Authorization Status Checking the status of submitted authorizations |
831-430-5511 |
Pharmacy Authorizations, general pharmacy information or questions |
831-430-5507 |